Cargando…
Ganoderma lucidum Extract Reduces the Motility of Breast Cancer Cells Mediated by the RAC–Lamellipodin Axis
Breast cancer (BC) is the second leading cause of cancer death among women worldwide. The main cause of BC morbidity and mortality is the invasiveness capacity of cancer cells that may lead to metastasis. Here, we aimed to investigate the therapeutic efficacy of Ganoderma lucidum extract (GLE)—a med...
Autores principales: | Acevedo-Díaz, Ariana, Ortiz-Soto, Gabriela, Suárez-Arroyo, Ivette J., Zayas-Santiago, Astrid, Martínez Montemayor, Michelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567024/ https://www.ncbi.nlm.nih.gov/pubmed/31109134 http://dx.doi.org/10.3390/nu11051116 |
Ejemplares similares
-
Identification of Biologically Active Ganoderma lucidum Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities in vitro
por: Martínez-Montemayor, Michelle M., et al.
Publicado: (2019) -
Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models
por: Suarez-Arroyo, Ivette J., et al.
Publicado: (2013) -
SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways
por: Acevedo-Díaz, Ariana, et al.
Publicado: (2022) -
Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer
por: Suárez-Arroyo, Ivette J., et al.
Publicado: (2017) -
Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression
por: Suárez-Arroyo, Ivette J., et al.
Publicado: (2016)